CD7 and hematologic disorder: Hu et al., conducted a study on CD7KO CD7-CAR-T in patients with CD7-positive hematologic malignancies, including one patient with CD7-positive r/r AML who achieved CRi and underwent allo-HSCT three months after CAR-T infusion [37].